Terms: = Leukemia AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL
41165 results:
1. Therapeutic Inducers of Natural Killer cell Killing (ThINKK): preclinical assessment of safety and efficacy in allogeneic hematopoietic stem cell transplant settings.
Poirier N; Paquin V; Leclerc S; Lisi V; Marmolejo C; Affia H; Cordeiro P; Théorêt Y; Haddad E; Andelfinger G; Lavallée VP; Duval M; Herblot S
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38754915
[TBL] [Abstract] [Full Text] [Related]
2. Impact of Fee For Service on the Efficiency and Survival of Seguro Popular's Patients With Acute Lymphoblastic leukemia in Mexico.
Cerecero-García D; Macías-González F; Muñoz-Aguirre P; Huerta-Gutierrez R; Zapata M; Rivera-Luna R; Lajous M; Bautista-Arredondo S
JCO Glob Oncol; 2024 May; 10():e2300060. PubMed ID: 38754053
[TBL] [Abstract] [Full Text] [Related]
3. Periorbital cellulitis as the initial presentation of acute lymphoblastic leukaemia.
Han-Menz C; Kozgar SAM; Rana MS
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38749518
[TBL] [Abstract] [Full Text] [Related]
4. Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs.
Heim D; Baldomero H; Medinger M; Masouridi-Levrat S; Schanz U; Nair G; Güngör T; Halter J; Passweg JR; Chalandon Y;
Swiss Med Wkly; 2024 May; 154():3754. PubMed ID: 38749067
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Characteristics and Diagnosis of Ph-Positive Mixed Phenotype Acute leukemia.
Zhang X; Li R; Zhang X; Li J; Li X; Chen J; Li H
Clin Lab; 2024 May; 70(5):. PubMed ID: 38747916
[TBL] [Abstract] [Full Text] [Related]
6. Case report: Preventive infusion of donor-derived CD7 chimeric antigen receptor T cells after allogeneic hematopoietic stem cell transplantation.
Jiang Y; Feng D; Zhu J; Wei D; Zhao C; Liu H; Shao S; Wang C
Front Immunol; 2024; 15():1381308. PubMed ID: 38745670
[TBL] [Abstract] [Full Text] [Related]
7. Targeted degradation of oncogenic bcr-ABL by silencing the gene of NEDD8 E3 ligase RAPSYN.
Sun Y; Wang Y; Liu C; Huang Y; Long Q; Ju C; Zhang C; Chen Y
J Nanobiotechnology; 2024 May; 22(1):247. PubMed ID: 38741123
[TBL] [Abstract] [Full Text] [Related]
8. Constitutional and acquired genetic variants in ARID5B in pediatric B-cell precursor acute lymphoblastic leukemia.
Ragnarsson C; Yang M; Moura-Castro LH; Aydın E; Gunnarsson R; Olsson-Arvidsson L; Lilljebjörn H; Fioretos T; Duployez N; Zaliova M; Zuna J; Castor A; Johansson B; Paulsson K
Genes Chromosomes Cancer; 2024 May; 63(5):e23242. PubMed ID: 38738968
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive analysis of the efficacy and safety of CAR T-cell therapy in patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: a systematic review and meta-analysis.
Willyanto SE; Alimsjah YA; Tanjaya K; Tuekprakhon A; Pawestri AR
Ann Med; 2024 Dec; 56(1):2349796. PubMed ID: 38738799
[TBL] [Abstract] [Full Text] [Related]
10. Foetal haemoglobin elevation, unfavourable prognosis, and protective role of genetic variants
Borrayo-LóPez FJ; Ibarra-Cortés B; Perea-Díaz F; MuñOz-Zúñiga AI; Montoya-Fuentes H; Soto-Padilla JM; Rizo-De La Torre LDC
J Genet; 2024; 103():. PubMed ID: 38736250
[TBL] [Abstract] [Full Text] [Related]
11. Triple Trouble.
Diwan A; Barsode S
J Assoc Physicians India; 2024 Mar; 72(3):97-99. PubMed ID: 38736127
[TBL] [Abstract] [Full Text] [Related]
12. Valrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers.
Georgievski A; Bellaye PS; Tournier B; Choubley H; Pais de Barros JP; Herbst M; Béduneau A; Callier P; Collin B; Végran F; Ballerini P; Garrido C; Quéré R
Cell Death Dis; 2024 May; 15(5):328. PubMed ID: 38734740
[TBL] [Abstract] [Full Text] [Related]
13. Inotuzumab ozogamicin for the treatment of adult acute lymphoblastic leukemia: past progress, current research and future directions.
Short NJ; Jabbour E; Jain N; Kantarjian H
J Hematol Oncol; 2024 May; 17(1):32. PubMed ID: 38734670
[TBL] [Abstract] [Full Text] [Related]
14. The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic leukemia.
Verbeek MWC; van der Velden VHJ
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732101
[TBL] [Abstract] [Full Text] [Related]
15. A Structural In Silico Analysis of the Immunogenicity of L-Asparaginase from
Andrade KCR; Homem-de-Mello M; Motta JA; Borges MG; de Abreu JAC; de Souza PM; Pessoa A; Pappas GJ; de Oliveira Magalhães P
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732010
[TBL] [Abstract] [Full Text] [Related]
16. Frequency and Aberrant CD Marker Profile of Acute Leukaemias.
Arshad MZ; Hassan MA; Bibi M; Hussain M; Alam M; Riaz MO
J Coll Physicians Surg Pak; 2024 May; 34(5):539-544. PubMed ID: 38720213
[TBL] [Abstract] [Full Text] [Related]
17. [Chronic myeloid leukemia with e6a2 fusion gene: a case report and literature review].
Li JJ; Yue LL; Zeng PY; Wu CY; Chen HL
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):299-302. PubMed ID: 38716604
[TBL] [Abstract] [Full Text] [Related]
18. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
[No Abstract] [Full Text] [Related]
19. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia].
Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596
[No Abstract] [Full Text] [Related]
20. [Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study].
Zhang XS; Liu BC; Du X; Zhang YL; Xu N; Liu XL; Li WM; Lin H; Liang R; Chen CY; Huang J; Yang YF; Zhu HL; Pan L; Wang XD; Li GH; Liu ZG; Zhang YQ; Liu ZF; Hu JD; Liu CS; Li F; Yang W; Meng L; Han YQ; Lin LE; Zhao ZY; Tu CQ; Zheng CF; Bai YL; Zhou ZP; Chen SN; Qiu HY; Yang LJ; Sun XL; Sun H; Zhou L; Liu ZL; Wang DY; Guo JX; Pang LP; Zeng QS; Suo XH; Zhang WH; Zheng YJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):215-224. PubMed ID: 38716592
[No Abstract] [Full Text] [Related]
[Next]
